CrushSCI.com
113.7Average days
83Median days
38Fastest days
356Longest days
1392025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

40 days

The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications

Authors
Ke Zhang; Xiao-Han Zhang; Xue-Chun Qu; Jing Zhang; Jia-Feng Li; Pei-Hao Sun; Ruo-Yu Xu; Wei-Rong Si; Qi-Ying Jiang; Dong-Dong WuShow moreShow less
Affiliations
1. Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, China; 2. School of Basic Medical Sciences, Henan University, Kaifeng, China; 3. Department of Stomatology, Huaihe Hospital of Henan University, School of Stomatology, Henan University, Kaifeng, China; 4. Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
73 days

Role of pyroptosis in breast cancer: Molecular mechanisms and therapeutic strategies

Authors
Xue-Chun Qu; Jing Zhang; Ke Zhang; Xiao-Han Zhang; Jia-Feng Li; Pei-Hao Sun; Ruo-Yu Xu; Wei-Rong Si; Tie-Shan Teng; Dong-Dong WuShow moreShow less
Affiliations
1. Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, China; 2. School of Basic Medical Sciences, Henan University, Kaifeng, China; 3. Department of Stomatology, School of Stomatology, Huaihe Hospital of Henan University, Henan University, Kaifeng, China; 4. Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
39 days

Cell-type-specific programmed cell death imbalance drives immune checkpoint blockade resistance in microsatellite-stable colorectal cancer

Authors
Jiazhi Yi; Shuyun Wu; Hongxia HeShow moreShow less
Affiliations
1. Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Zunyi, China; 2. Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China; 3. Department of Gastroenterology, The Eighth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; 4. Department of Hospital Infection Control, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaShow moreShow less
Source PDF DOI Publisher page
52 days

ZNF460–SNRPB–RDM1 splicing axis promotes clear cell renal cell carcinoma progression through regulation of DNA damage repair

Authors
Kang Liu; Yao Yao; Han Xiang; Yang Wang; Chunchao Jiang; Lixia Wang; Jin ZhuShow moreShow less
Affiliations
1. Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
112 days

Targeting the Nrf2-SIRT1 axis abrogates metabolic plasticity and sensitizes breast cancer to oxidative stress

Authors
Chen-Chun Liu; Kai-Hsi Lu; Jhih-Pu Syu; Hsiu-Ni KungShow moreShow less
Affiliations
1. Department of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei, Taiwan; 2. Heart Center, Cheng-Hsin General Hospital, Taipei, TaiwanShow moreShow less
Source PDF DOI Publisher page
73 days

Regorafenib induces ferroptosis in hepatocellular carcinoma via the EGFR-TNF/NF-κB signaling axis

Authors
Bing-Kun Wang; Jia-Hao Jiang; Zhi-Qin Xie; Qing-Bin Wang; Xiao-Wu Ma; Zi-Yu Zhang; Zu-Yi Ma; Yong-Lin Hua; Yu-Xin Xiao; Hong-Kai Zhuang; Chang-Zhen Shang; Ya-Jin ChenShow moreShow less
Affiliations
1. Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 3. Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 4. Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China; 5. Hunan Key Laboratory for the Prevention and Treatment of Biliary Tract Diseases, Changsha, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does APOPTOSIS take to review a manuscript?

As of 2026-11-18, CrushSCI has 30 complete review records for APOPTOSIS. The fastest paper went from submission to acceptance in 38 days (Compartmental pH regulation in cancer and antitumor immunity: therapeutic opportunities and challenges, received 2026-06-05, accepted 2026-07-13); the slowest took 356 days. The average is 113.7 days and the median is 83 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.